QLSF Biotherapeutics Pipeline
| Drug | Indication | Phase |
|---|
| QL401 | Cancer | Phase 1 |
| QL325 | Acute Myeloid Leukemia | Phase 1 |
| QL335 | Colorectal Cancer | Phase 1 |
| QL535 | Cancer | IND-Enabling |
| QL555 | Cancer | Preclinical |
| QL615 | Cancer | Preclinical |
| QL301 | Cancer | Phase 1/2 |
| QL415 | Cancer | Phase 1 |